This article is from the Amalgam and Mercury-free Dentistry FAQ.
There has always been a very small minority of the individuals that
have undergone amalgam replacement that have not benefited from
it. This has caused a great deal of discouragement in the individual
and the health professional working with them. In some instances it
has been related to the materials and procedures used by the dentist
that did the work. In others it was assumed that their health problems
were caused by something other than mercury or that the damage caused
by mercury was irreversible. Whatever the reason, it was very little
comfort to the individual not seeing any improvement. Now however,
thanks to some very advanced research in Sweden, it appears there may
be an answer for many of these intractable cases.
Dr. Christer Malmström in Sweden has discovered that most of the
people who do not see health improvements after amalgam replacement
appear to have diverticula or impacted fecal matter in their colon
that contains high levels of toxic metals. Upon removal of these
metals, great progress can be seen in the individual's
health. (Appendix B of the book ''Dental Mercury Detox'' contains the
complete ''Malstrom Protocol)
IT IS IMPORTANT THAT EVERYONE UNDERSTAND THAT THERE ARE NO GUARANTEES
THAT AMALGAM REPLACEMENT WILL AMELIORATE, CURE OR SOLVE YOUR
INDIVIDUAL HEALTH PROBLEMS!
However, even in those cases where there hasn't been any great
improvement, these individuals can take comfort from the fact that
they have eliminated a constant source of poison entering their
body. The vast majority of individuals who have undergone amalgam
replacement and the reduction of their mercury body burden have
experienced improvements in health that have ranged from minor to
startlingly dramatic. For example the statistics listed below were
compiled by the Foundation For Toxic- Free Dentistry (FTFD) on 1569
patients from 6 different reports.
The statistical analysis involves a total of 1569 patients in six
different studies: 762 patients utilized the FTFD Patient Adverse
Reaction Report to individually report changes in their health
directly to the FDA and the FTFD; Dr. Mats Hanson, Ph.D. reported on
519 Swedish patients; Henrik Lichtenberg, D.D.S. of Denmark reported
on 100 patients; Pierre LaRose, D.D.S. of Canada reported on 80
patients; Robert L. Siblerud O.D., M.S. reported on 86 patients in
Colorado as partial fulfillment of a Ph.D. requirement; and Albert
V. Zamm, M.D., FACA, FACP reported on 22 of his patients.
FTFD SYMPTOM ANALYSIS OF 1569 PATIENTS % of total SYMPTOM No.
No. improved or cured % of cure or improvement
14% ALLERGY 221 196 89% 5% ANXIETY 86 80 93% 5% BAD TEMPER 81 68 89% 6% BLOOD PRESSURE PROBLEMS 99 53 54% 5% CHEST PAINS 79 69 87% 22% DEPRESSION 347 315 91% 22% DIZZINESS 343 301 88% 45% FATIGUE 705 603 86% 15% GASTROINTESTINAL PROBLEMS 231 192 83% 8% GUM PROBLEMS 129 121 94% 34% HEADACHES 531 460 87% 3% MIGRAINE HEADACHES 45 39 87% 12% INSOMNIA 187 146 78% 10% IRREGULAR HEARTBEAT 159 139 87% 8% IRRITABILITY 132 119 90% 17% LACK OF CONCENTRATION 270 216 80% 6% LACK OF ENERGY 91 88 97% 17% MEMORY LOSS 265 193 73% 17% METALLIC TASTE 260 247 95% 7% MULTIPLE SCLEROSIS 113 86 76% 8% MUSCLE TREMOR 126 104 83% 10% NERVOUSNESS 158 131 83% 8% NUMBNESS ANYWHERE 118 97 82% 20% SKIN DISTURBANCES 310 251 81% 9% SORE THROAT 149 128 86% 6% TACHYCARDIA 97 68 70% 4% THYROID PROBLEMS 56 44 79% 12% ULCERS & SORES (ORAL CAVITY) 189 162 86% 7% URINARY TRACT PROBLEMS 115 87 76% 29% VISION PROBLEMS 462 289 63%
 
Continue to: